About Lagniappe- RxLPS
Lagniappe- RxLPS is a company based in Fort Worth (United States) founded in 2011 was acquired by Rx30 Pharmacy Software in May 2016. Lagniappe- RxLPS has raised $9.54 million across 1 funding round from investors including Rx30 Pharmacy Software. The company has 198 employees as of December 31, 2020. Lagniappe- RxLPS has completed 1 acquisition, including OPUS-ISM. Lagniappe- RxLPS offers products and services including Pharmacy Software, Pharmacy Point-of-Sale, Patient Management, Patient Communication, and Support Services. Lagniappe- RxLPS operates in a competitive market with competitors including mPharma, Pharmarack, KareXpert, OmniSYS and Xevant, among others.
- Headquarter Fort Worth, United States
- Employees 198 as on 31 Dec, 2020
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Lagniappe Health Acquisition Company, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$9.54 M (USD)
in 1 rounds
-
Latest Funding Round
$9.54 M (USD), Series A
Sep 05, 2014
- Investors
-
Employee Count
198
as on Dec 31, 2020
- Investments & Acquisitions
-
Acquired by
Rx30 Pharmacy Software
(May 17, 2016)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Lagniappe- RxLPS
Lagniappe- RxLPS offers a comprehensive portfolio of products and services, including Pharmacy Software, Pharmacy Point-of-Sale, Patient Management, Patient Communication, and Support Services.
Software for pharmacy operations and inventory management
System for handling sales and transactions in pharmacies
Tools for managing patient records and interactions
Software for patient engagement and messaging
Services for technical assistance and system maintenance
Funding Insights of Lagniappe- RxLPS
Lagniappe- RxLPS has successfully raised a total of $9.54M through 1 strategic funding round. The most recent funding activity was a Series A round of $9.54 million completed in September 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $9.5M
-
First Round
First Round
(05 Sep 2014)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2014 | Amount | Series A - Lagniappe- RxLPS | Valuation |
investors |
|
Investors in Lagniappe- RxLPS
Lagniappe- RxLPS has secured backing from 1 investor. Prominent investors backing the company include Rx30 Pharmacy Software.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Pharmacy management software and integrated solutions are provided.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Lagniappe- RxLPS
Lagniappe- RxLPS has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include OPUS-ISM.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Limited information is available on core activities.
|
2004 |
Financial Statements - Lagniappe- RxLPS
Lagniappe- Rxlps Comparisons
Competitors of Lagniappe- RxLPS
Lagniappe- RxLPS operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as mPharma, Pharmarack, KareXpert, OmniSYS and Xevant, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of pharmacy management services and software for stock management for patients and pharmacies
|
|
| domain | founded_year | HQ Location |
SaaS-based pharmacy management solutions are offered to retailers and distributors.
|
|
| domain | founded_year | HQ Location |
Cloud-based software suite for healthcare providers is offered.
|
|
| domain | founded_year | HQ Location |
Offers medical billing services for pharmacies and manages business policies and relationships.
|
|
| domain | founded_year | HQ Location |
A SaaS-based platform for pharmacy benefit management is provided.
|
|
| domain | founded_year | HQ Location |
AI-driven pharmacy benefit management software is provided for pharmacies.
|
Latest news on Lagniappe- Rxlps
Frequently Asked Questions about Lagniappe- RxLPS
Lagniappe- RxLPS was founded in 2011 and raised its 1st funding round 3 years after it was founded.
Lagniappe- RxLPS is headquartered in Fort Worth, United States. It is registered at Fort Worth, Texas, United States.
Lagniappe- RxLPS is a funded company, having raised a total of $9.54M across 1 funding round to date. The company's 1st funding round was a Series A of $9.54M, raised on Sep 05, 2014.
As of Dec 31, 2020, the latest employee count at Lagniappe- RxLPS is 198.
Founded in 2011 and based in Fort Worth, United States, Lagniappe RxLPS operates in the pharmacy software sector. Windows-based RX-1 Pharmacy Software System is offered, featuring touchscreen-driven tools for prescription filling. Integration with touchPOS, a point-of-sale product, enables direct posting of accounts receivable to pharmacy files and tracks prescription statuses such as sold, available, or pending. Value-added services support overall pharmacy operations.
Lagniappe- RxLPS's top competitors include mPharma, Scripta Insights and KareXpert.
Lagniappe- RxLPS offers Pharmacy Software, Pharmacy Point-of-Sale, Patient Management, Patient Communication, and Support Services.
Lagniappe- RxLPS has made 1 acquisition, including OPUS-ISM.
Lagniappe- RxLPS has 1 investor. Key investors include Rx30 Pharmacy Software.